A Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of GLH8NDE After Single and Mutiple Ocular Administrations in Healthy Korean and Caucasian Volunteers
Clinical trial NCT04104997 · COMPLETED
Trial details
- NCT number
- NCT04104997
- Sponsor
- GL Pharm Tech Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-26
- Primary completion
- 2020-02-18
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.